Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors-based therapy

Autor: Matthew L. Albert, Yoann Barthe, Armanda Casrouge, Arnaud Fontanet, Stanislas Pol, Sylvie Lagaye, Hélène Fontaine, Vincent Mallet, Philippe Sultanik, Christophe Hézode, Estelle Mottez, Laurent Abel, Etienne Gayat, Céline Dorival, Fabrice Carrat, Jean-Pierre Bronowicki, Ioannis Theodorou

Publikováno v: Liver International
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, 2015, 35 (7), pp.1833-1844. ⟨10.1111/liv.12759⟩
Liver International, Wiley-Blackwell, 2015, 35 (7), pp.1833-1844. 〈10.1111/liv.12759〉

International audience; BACKGROUND & AIMS:Chronic infection with HCV remains a public health problem with approximately 150 million people infected worldwide. HCV intersects with lipid metabolism for replication and entry; and plasma concentrations o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90633f842d8de6ea3f7f4df0ad3c882d
https://doi.org/10.1111/liv.12759

Assessing the cost-effectiveness of hepatitis C screening strategies in France

Autor: Deuffic-Burban, Sylvie, Huneau, Alexandre, Verleene, Adeline, Brouard, Cécile, Pillonel, Josiane, Le Strat, Yann, Cossais, Sabrina, Roudot-Thoraval, Françoise, Canva, Valérie, Mathurin, Philippe, Dhumeaux, Daniel, Yazdanpanah, Yazdan

Publikováno v: Journal of Hepatology
Journal of Hepatology, 2018, 69 (4), pp.785-792. ⟨10.1016/j.jhep.2018.05.027⟩

International audience; BACKGROUND & AIMS:In Europe, hepatitis C virus (HCV) screening still targets people at high risk of infection. We aim to determine the cost-effectiveness of expanded HCV screening in France.METHODS:A Markov model simulated chr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::9acfe6bc82d6f014c3ccc036f3ed5ad1
https://www.hal.inserm.fr/inserm-02472188/document